307 related articles for article (PubMed ID: 23639374)
21. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.
Goodfellow JA; Bowes T; Sheikh K; Odaka M; Halstead SK; Humphreys PD; Wagner ER; Yuki N; Furukawa K; Furukawa K; Plomp JJ; Willison HJ
J Neurosci; 2005 Feb; 25(7):1620-8. PubMed ID: 15716397
[TBL] [Abstract][Full Text] [Related]
22. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
23. Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies.
Uncini A; Notturno F; Capasso M
Muscle Nerve; 2013 Oct; 48(4):484-7. PubMed ID: 23625341
[TBL] [Abstract][Full Text] [Related]
24. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
25. Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies.
Yu RK; Ariga T; Usuki S; Kaida K
Adv Exp Med Biol; 2011; 705():349-65. PubMed ID: 21618117
[No Abstract] [Full Text] [Related]
26. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
27. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
Yuki N; Uncini A
Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural Lesions of Nodo-Paranodopathies in Peripheral Neuropathies.
Vallat JM; Magy L; Corcia P; Boulesteix JM; Uncini A; Mathis S
J Neuropathol Exp Neurol; 2020 Mar; 79(3):247-255. PubMed ID: 31923310
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
31. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Lim JP; Devaux J; Yuki N
Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
[TBL] [Abstract][Full Text] [Related]
32. Nodal conduction block: A unifying concept.
Oh SJ
Muscle Nerve; 2021 Feb; 63(2):178-180. PubMed ID: 33184867
[TBL] [Abstract][Full Text] [Related]
33. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
34. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
Rajabally YA; Hassan-Smith G; Notturno F; Eames PJ; Hayton T; Capasso M; Uncini A
J Neurol Sci; 2011 Apr; 303(1-2):35-8. PubMed ID: 21316711
[TBL] [Abstract][Full Text] [Related]
35. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
Moran AP; Annuk H; Prendergast MM
J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
[TBL] [Abstract][Full Text] [Related]
36. Another brick in the wall: is hexane neuropathy a 'nodo-paranodopathy'?
Alpaydin Baslo S; Ozturk O; Dayan C; Atakli D; Baslo MB
Acta Neurol Belg; 2021 Apr; 121(2):373-378. PubMed ID: 30982200
[TBL] [Abstract][Full Text] [Related]
37. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.
Fewou SN; Rupp A; Nickolay LE; Carrick K; Greenshields KN; Pediani J; Plomp JJ; Willison HJ
J Clin Invest; 2012 Mar; 122(3):1037-51. PubMed ID: 22307327
[TBL] [Abstract][Full Text] [Related]
38. Nodes, paranodes and neuropathies.
Fehmi J; Scherer SS; Willison HJ; Rinaldi S
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):61-71. PubMed ID: 28819062
[TBL] [Abstract][Full Text] [Related]
39. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
Bae JS; Kim BJ
J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
